World Investment Advisors Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

World Investment Advisors bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 8,457 shares of the exchange traded fund’s stock, valued at approximately $762,000.

Other hedge funds have also bought and sold shares of the company. FMR LLC raised its stake in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC increased its holdings in SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after acquiring an additional 1,137 shares during the last quarter. Van ECK Associates Corp bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at about $1,497,000. Parallel Advisors LLC lifted its holdings in SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock valued at $3,834,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its position in SPDR S&P Biotech ETF by 4.4% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 160,402 shares of the exchange traded fund’s stock worth $14,445,000 after purchasing an additional 6,771 shares during the period.

SPDR S&P Biotech ETF Trading Down 5.7 %

Shares of XBI stock opened at $73.66 on Monday. The firm’s 50 day moving average is $88.13 and its 200 day moving average is $93.12. The stock has a market capitalization of $4.65 billion, a P/E ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 12 month low of $70.16 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.